-
News | 2023.06.16
Strategic Plan: research advances in 2022
Five major themes were at the core of 2022 research advances: emerging infectious diseases, antimicrobial resistance, brain connectivity and neurodegenerative diseases, cancer, vaccinology and immunotherapy. They have honored Institut Pasteur's 2019-2023 strategic plan.
-
News | 2023.07.10
Enteric viruses with similar genomes in humans and great apes
A study conducted in Cameroon looked at enteric viruses in humans and some great ape species. These viruses share the same genomes. This "sharing" is thought to be a result of hunting, meat consumption and pillaging by great apes. The findings confirm the scale of pathogen transmission between humans and animals, which can represent a threat to human and animal health.
-
Document de presse | 2023.07.11
A global overview of antibiotic resistance determinants
To understand the main determinants behind worldwide antibiotic resistance dynamics, scientists from the Institut Pasteur, Inserm, Université de Versailles Saint-Quentin-en-Yvelines and Université Paris-Saclay developed a statistical model based on a large-scale spatial-temporal analysis. Using the ATLAS antimicrobial resistance surveillance database, the model revealed significant differences in...
-
Document de presse | 2023.07.12
Genetic variants implicated in autism detected in the general population
Scientists from the Institut Pasteur, the CNRS, the Institut universitaire de France, Université Paris Cité and the Paris Public Hospital Network (AP-HP) compared genetic data from 13,000 individuals with autism and nearly 200,000 individuals from the general population. While 4% of those with autism were found to carry strong genetic variations implicated in autism, the same variations were also...
-
Document de presse | 2023.07.20
HIV: 20 months' remission after a bone marrow transplant with no protective mutation – the Geneva patient
In February 2023, the IciStem consortium, which includes Asier Sáez-Cirión's team at the Institut Pasteur, published details in Nature Medicine of a third case of HIV remission after a bone marrow transplant, involving the Düsseldorf patient. A total of 5 individuals (the Berlin, London, Düsseldorf, New York and City of Hope patients) are now considered as having probably been cured of HIV...
-
News | 2023.07.24
Framework Agreement between the Institut Pasteur and Fiocruz for the Development of Innovation and Technology Transfer
The Institut Pasteur and the Oswaldo Cruz Foundation (Fiocruz) have a long-standing partnership, mirroring the strong ties between France and Brazil, which have maintained a privileged relationship in the fields of public health and biomedical research for over a century. With this framework agreement, the two institutions reinforce their bilateral relations while leveraging the complementarity...
-
Document de presse | 2023.07.27
Remission from HIV-1 infection: discovery of broadly neutralizing antibodies that contribute to virus control
Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms enabling this post-treatment control have not been fully elucidated. For the first time, teams of scientists from the Institut Pasteur, Inserm and the Paris Public Hospital Network (AP-HP), supported by...
-
News | 2023.08.17
ECOMORE 2: understanding environmental impact on the emergence of infectious diseases in Southeast Asia.
Due to population growth and economic development, our planet is experiencing significant changes in natural ecosystems that may lead to the re-emergence of infectious diseases. For 5 years, ECOMORE 2 project, coordinated by Institut Pasteur in partnership with the Institut Pasteur du Cambodge, the Institut Pasteur du Laos, the National Health Laboratory (NHL) of Myanmar, the Research Institute...
-
Document de presse | 2023.08.09
SARS-CoV-2: how the history of human populations influences their immune response
During the COVID-19 pandemic, the clinical spectrum observed among people infected with SARS-CoV-2 ranged from asymptomatic carriage to death. Researchers at the Institut Pasteur, the CNRS and the Collège de France, in collaboration with researchers around the world1 , have investigated the extent and drivers of differences in immune responses to SARS-CoV-2 across populations from Central Africa...
-
News | 2023.08.23
Distinct immune responses reveal two major types of long COVID
Although the biological mechanisms behind the short-term effects of COVID-19 are now known, the same is not true for long COVID. Scientists have recently demonstrated that individuals with this syndrome can present different immune responses, either weak or strong. This is a first step in improving treatment for patients with no apparent immunological traces of SARS-CoV-2 infection.
